A month after learning that the cancer had spread to her liver, Katie flew to New York for her consult on the Phase 2 trial at Memorial ... Her oncologist ordered a brain MRI, which revealed ...

Partners in Equity V B.V. / Partners in Equity III B.V. / Johan Gijsbert Wackwitz and Renée Marie Henriëtte Roebbers (5) Passive crossing of a threshold 9,066,912 17.30% (1) The total number of ...

The firm plans to build on its organ and tissue modeling technology to develop more sophisticated tests, including full-body digital twins.

In Mayo we live beside the Atlantic Ocean. It’s highly probable that we will see more chaos and destruction as the years move ...

Depending on the specific interferon you are taking, your healthcare provider may monitor bloodwork (like liver ... Three years after stem cell transplantation, 17 of them (70%) had no MS disease ...

Research scientists in Switzerland have developed and tested a robust AI model that automatically segments major anatomic ...

Over 7,800 people have benefited from this service in the last three months. CMCH introduced its first MRI scan in 2018, and the waiting time for outpatients was around 2-3 days. As each scan took ...

Ex-Takeda VP Tauhid Ali, Ph.D., with broad leadership and drug development experience becomes Board DirectorSeasoned regulatory strategist Darren ...

Horizon Therapeutics Plc presented positive new MRI data from the phase 3 clinical trial of UPLIZNA (inebilizumab) at the 9th Congress of the European Academy of Neurology (EAN) in Budapest ...

Three patients with unmutated (wildtype) FLT3 (FLT3-WT) completed Cycle 1 of treatment with no dose-limiting toxicities (DLTs) and no dose adjustments. Two FLT3-WT patients achieved complete ...